Prediction of ion channel activity using binary kernel discrimination

Journal of Chemical Information and Modeling

Volumn 47, Issue 5, 2007, Pages 1961-1966

  Willett, Peter ^a   Wilton, David ^a   Hartzoulakis, Basil ^b   Tang, Raymond ^b   Ford, John ^b   Madge, David ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Xention Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; DATA ACQUISITION; LEARNING SYSTEMS; PROTEINS;

BINARY KERNEL DISCRIMINATION (BKD); CHEMOINFORMATICS; ION CHANNEL ACTIVITY; VOLTAGE-GATED ION CHANNELS;

DRUG PRODUCTS;

ION CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT;

ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; BIOLOGY; CHANNEL GATING; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DRUG SCREENING; ELECTROPHYSIOLOGY; METABOLISM; REPRODUCIBILITY;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; ELECTROPHYSIOLOGY; ION CHANNEL GATING; ION CHANNELS; MODELS, CHEMICAL; POTASSIUM CHANNEL BLOCKERS; REPRODUCIBILITY OF RESULTS; SODIUM CHANNEL BLOCKERS;

EID: 35248878132     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci700087v     Document Type: Article

References (40)

1. Hille, B.; Armstrong, C. M.; MacKinnon, R. Ion Channels: From Idea to Reality. Nat. Med. (New York, NY, U.S.) 1999, 5 (10), 1105-1109.
2. Loussouarn, G.; Rose, T.; Nichols, C. G. Structural Basis of Inward Rectifying Potassium Channel Gating. Trends Cardiovasc. Med. 2002, 12, 253-258.
3. Niemeyer, B. A. Structure-Function Analysis of TRPV Channels. Naunyn-Schmiedeberg's Arch. Pharmacol. 2005, 371, 285-294.
4. Nilius, B.; Talavera, K.; Owsianik, G.; Prenen, J.; Droogmans, G.; Voets, T. Gating of TRP Channels: A Voltage Connection? J. Physiol. 2005, 567, 35-44.
5. McKemy, D. D. How Cold Is It? TRPM8 and TRPA1 in the Molecular Logic of Cold Sensation. Mol. Pain 2005, 7, 16.
6. Yu, F. H.; Catterall, W. A. Overview of the Voltage-Gated Sodium Channel Family. Genome Biol. 2003, 4, 207.
7. Ogata, N.; Ohishi, Y. Molecular Diversity of Structure and Function of the Voltage-Gated Na+ channels. Jpn. J. Pharmacol. 2002, 88, 365-377.
8. Nattel, S.; Carlsson, L. Innovative Approaches to Anti-Arrhythmic Drug Therapy. Nat. Rev. Drug Discovery 2006, 5, 1034-1049.
9. Lai, H. C.; Jan, L. Y. The Distribution and Targeting of Neuronal Voltage-Gated Ion Channels. Nat. Rev. Neurosci. 2006, 7, 548-562.
10. Ekberg, J.; Adams, D. J. Neuronal Voltage-Gated Sodium Channel Subtypes: Key Roles in Inflammatory and Neuropathic Pain. Int. J. Biochem. Cell Biol. 2006, 38, 2005-2010.
11. Gribkoff, V. K. The Role of Voltage-Gated Calcium Channels in Pain and Nociception. Semin. Cell Dev. Biol. 2006, 17, 555-564.
12. Anger, T.; Madge, D. J.; Mulla, M.; Riddall, D. Medicinal Chemistry of Neuronal Voltage-Gated Sodium Channel Blockers. J. Med. Chem. 2001, 44, 115-137.
13. Jamieson, C.; Moir, E. M.; Rankovic, Z.; Wishart, G. Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups. J. Med. Chem. 2006, 49, 5029-5046.
14. Long, S. B.; Campbell, E. B.; MacKinnon, R. Crystal Structure of a Mammalian Voltage-Dependent Shaker Family K+ Channel. Science 2005, 309, 897-903.
15. Pirard, B.; Brendel, J.; Peukert, S. The Discovery of Kvl.5 Blockers as a Case Study for the Application of Virtual Screening Approaches. J. Chem. Inf. Model. 2005, 45, 477-485.
16. Klebe, G. Virtual Screening: An Alternative or Complement to High Throughput Screening?; Kluwer Academic Publishers: Dordrecht, Netherlands, 2000.
17. Schneider, G.; Bohm, H. J. Virtual Screening and Fast Automated Docking Methods. Drug Discovery Today 2002, 7, 64-70.
18. Ebner, T. J.; Chen, G. Spreading Acidification and Depression in the Cerebellar Cortex. Neuroscientist 2003, 9, 37-45.
19. Chandy, K. G.; Wulff, H.; Beeton, C.; Pennington, M.; Gutman, G. A.; Cahalan, M. D. K+ Channels as Targets for Specific Immunomodulation. Trends Pharmacol. Sci. 2004, 25, 280-289.
20. Beeton, C.; Chandy, K. G. Potassium Channels, Memory T Cells, and Multiple Sclerosis. Neuroscientist 2005, 11, 550-562.
21. Nattel, S.; Khairy, P.; Roy, D.; Thibault, B.; Guerra, P.; Talajic, M.; Dubuc, M. New Approaches to Atrial Fibrillation Management: A Critical Review of a Rapidly Evolving Field. Drugs 2002, 62, 2377-2397.
22. Decher, N.; Kumar, P.; Gonzalez, T.; Renigunta, V.; Sanguinetti, M. C. Structural Basis for Competition between Drug Binding and Kvbeta 1.3 Accessory Subunit-Induced N-type Inactivation of KvI .5 Channels. Mol. Pharmacol. 2005, 68, 995-1005.
23. Hains, B. C.; Saab, C. Y.; Waxman, S. G. Alterations in Burst Firing of Thalamic VPL Neurons and Reversal by Na(v)1.3 Antisense after Spinal Cord Injury. J. Neurophysiol. 2006, 95, 3343-3352.
24. Baker, M. D.; Wood, J. N. Involvement of Na+ Channels in Pain Pathways. Trends Pharmacol. Sci. 2001, 22, 27-31.
25. Birch, P. J.; Dekker, L. V.; James, I. F.; Southan, A.; Cronk, D. Strategies to Identify Ion Channel Modulators: Current and Novel Approaches to Target Neuropathic Pain. Drug Discovery Today 2004, 9, 410-418.
26. Owen, D. G.; Gerard, B. N.; Noorwood, J. H.; Piotrowski, V.; Silverthorne, A. Single Cell Auto Patch High Throughput Screen Improved Interface Patch Clamping. European Patents EP1274995, EP1621888, EP1290441, Feb 1, 2006.
27. Harper, G.; Bradshaw, J.; Gittins, J. C.; Green, D. V.; Leach, A. R. Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination. J. Chem. Inf. Comput. Sci. 2001, 41, 1295-1300.
28. Leach, A. R.; Gillet, V. J. An Introduction to Chemoinformatics; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2003.
29. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical Similarity Searching. J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
30. Sheridan, R. P.; Kearsely, S. K. Why Do We Need So Many Chemical Similarity Search Methods? Drug Discovery Today 2002, 7, 903-911.
31. Aitchison, J.; Aitken, C. G. G. Multivariate Binary Discrimination by the Kernel Method. Biometrika 1976, 63, 413-420.
32. Chen, B.; Harrison, R. F.; Pasupa, K.; Willett, P.; Wilton, D. J.; Wood, D. J.; Lewell, X. Q. Virtual Screening Using Binary Kernel Discrimination: Effect of Noisy Training Data and the Optimization of Performance. J. Chem. Inf. Model. 2006, 46, 478-486.
33. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures. J. Chem. Inf. Comput. Sci. 2004, 44, 1177-1185.
34. Wilton, D.; Willett, P.; Lawson, K.; Mullier, G. Comparison of Ranking Methods for Virtual Screening in Lead-Discovery Programs. J. Chem. Inf. Comput. Sci. 2003, 43, 469-474.
35. Wilton, D. J.; Harrison, R. F.; Willett, P.; Delaney, J.; Lawson, K.; Mullier, G. Virtual Screening Using Binary Kernel Discrimination: Analysis of Pesticide Data. J. Chem. Inf. Model. 2006, 46, 471-477.
36. Chen, B.; Harrison, R. F.; Papadatos, G.; Willett, P.; Wood, D. J.; Lewell, X. Q.; Greenidge, P.; Stiefl, N. Evaluation of MachineLearning Methods for Ligand-Based Virtual Screening. J. Comput.Aided Mol. Des. 2007, 27, 53-62.
37. Tripos Inc. http://www.tripos.com (accessed May 4, 2007).
38. Scitegic Inc. http://www.scitegic.com (accessed May 4, 2007).
39. Bender, A.; Mussa, H. Y.; Glen, R. C. Screening for Dihydrofolate Reductase Inhibitors Using MOLPRINT 2D, a Fast Fragment-Based Method Employing the Naive Bayesian Classifier: Limitations of the Descriptor and the Importance of Balanced Chemistry in Training and Test Sets. J. Biomol. Screening 2005, 10, 658-666.
40. The World Drugs Index Database (WDI). http://scientific.thomson.com/ products/wdi/ (accessed May 4, 2007).